Advert - Bayer

• Date posted
  08 August 2019
• Sanction
  Advertisement,
• Case number/s
  AUTH/3035/4/18 - Health Professional v Bayer

For a misleading claim about Xarelto (rivaroxaban) which potentially put the safety of patients with severe renal impairment at risk, Bayer was ruled in breach of the
following clauses:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.
Clause 7.2 - Making a misleading claim.
Clause 7.4 - Making an unsubstantiated claim.
Clause 9.1 - Failing to maintain high standards.